Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates
NCT00394784 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-12-11
Summary
This research is important because it allows for the determination of resistance rates to antibiotics that may not be frequently tested by the clinical microbiology laboratory at University of Pittsburgh Medical Center (UPMC)-Presbyterian. It also will provide antibiotic minimum inhibitory concentrations (MICs) for these pathogens which may help in identifying the best empiric antibiotic option for gram-negative blood stream infections based on known pharmacodynamic parameters.
Conditions
- Gram-negative Bacterial Infections
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Brian Potoski, PharmD · University of Pittsburgh
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
NCT03006679 ·Status: WITHDRAWN ·Phase: PHASE3
-
Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae
NCT03891433 ·Status: SUSPENDED ·Phase: PHASE4
-
Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections
NCT02753946 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
NCT00414193 ·Status: COMPLETED
-
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
NCT00177814 ·Status: COMPLETED
-
A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101
NCT05629741 ·Status: TERMINATED ·Phase: PHASE1
-
A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects
NCT01262885 ·Status: COMPLETED ·Phase: PHASE1
-
Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae
NCT00753558 ·Status: COMPLETED ·Phase: NA
-
DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
NCT00302341 ·Status: TERMINATED ·Phase: PHASE3
-
Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance
NCT01788449 ·Status: COMPLETED
-
Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
NCT07326540 ·Status: RECRUITING ·Phase: PHASE3
-
An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia
NCT00502801 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants
NCT03182504 ·Status: COMPLETED ·Phase: PHASE1
-
Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study
NCT00510614 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS
NCT00000640 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects
NCT01267968 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)
NCT00254696 ·Status: COMPLETED ·Phase: PHASE4
-
Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas
NCT03582007 ·Status: TERMINATED ·Phase: PHASE3
-
GSK2251052 in Complicated Urinary Tract Infection
NCT01381549 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia
NCT01853982 ·Status: TERMINATED ·Phase: PHASE3
-
PK of Piperacillin/Tazobactam in Adults Undergoing ECMO
NCT03467854 ·Status: TERMINATED
-
Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults
NCT02255760 ·Status: COMPLETED ·Phase: PHASE1
-
11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
NCT03424525 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Therapeutic Management in ESBL-infected Patients or Carriers by Providing and Sharing a Free Tool - the "ESBL toolKIT"and Interventional Study of a Prospective Cohort of HIV+ Patients Searching for Possible Sexual Transmission Factors in ESBL Carriers
NCT02011009 ·Status: COMPLETED ·Phase: NA
-
Oritavancin for Staphylococcus Aureus Infections in Opioid Users
NCT03761953 ·Status: WITHDRAWN ·Phase: PHASE4